EGFR and non-small cell lung carcinoma: Several studies demonstrated that a lower proportion of PD-L1-positive cells was present in NSCLC patients harboring EGFR mutations than in those harboring wild-type PD-L1, revealing a negative correlation between EGFR mutation status and PD-L1 expression (P = 0.003) [9].